A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine
NCT00343681
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Orthomyxoviridae Infections
Interventions
BIOLOGICAL:
Inactivated influenza vaccine (split virion)
Sponsor
Sanofi Pasteur, a Sanofi Company